KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Minority Interest (2016 - 2025)

Gilead Sciences' Minority Interest history spans 17 years, with the latest figure at -$84.0 million for Q4 2025.

  • For Q4 2025, Minority Interest changed 0.0% year-over-year to -$84.0 million; the TTM value through Dec 2025 reached -$84.0 million, changed 0.0%, while the annual FY2025 figure was -$84.0 million, 0.0% changed from the prior year.
  • Minority Interest reached -$84.0 million in Q4 2025 per GILD's latest filing, roughly flat from -$84.0 million in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of $12.0 million in Q1 2021 to a low of -$84.0 million in Q4 2023.
  • Average Minority Interest over 5 years is -$51.2 million, with a median of -$68.0 million recorded in 2023.
  • Peak YoY movement for Minority Interest: crashed 2500.0% in 2022, then changed 0.0% in 2024.
  • A 5-year view of Minority Interest shows it stood at -$5.0 million in 2021, then plummeted by 520.0% to -$31.0 million in 2022, then crashed by 170.97% to -$84.0 million in 2023, then changed by 0.0% to -$84.0 million in 2024, then changed by 0.0% to -$84.0 million in 2025.
  • Per Business Quant, the three most recent readings for GILD's Minority Interest are -$84.0 million (Q4 2025), -$84.0 million (Q3 2025), and -$84.0 million (Q2 2025).